We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to best protect patients and volunteers during magnetic resonance imaging (MRI) examinations.
Guidance on how to make reasonable adjustments to help support people with learning disabilities in using pharmacy services.
Interventions that can be made by pharmacy teams, to improve quality of life for older people.
Information for patients, public and healthcare professionals
New Cosmetic Breast Augmentation Risk Awareness Tool for patients to use when considering cosmetic breast implant surgery.
Guidance for manufacturers of coronary stents. It outlines specific scenarios that should be considered when determining if an incident is reportable.
If pharmacies wish to ‘pack down’ larger packs of a medicinal product, they need to follow these instructions
Guidance for holders of marketing authorisations (MAs) approved in Northern Ireland (NI) who want to bring a product to market in Great Britain (GB).
On this page the Medicines and Healthcare Products Regulatory agency provides advice for producers of E-cigarette/vape products
Due diligence for suppliers of e-cigarettes and e-liquids.
summary
Information relating to the disapplication of falsified medicines under UK Law.
Guidance for dispensing of valproate-containing medicines in the manufacturer’s original full pack, following amendments to the Human Medicines Regulations (HMRs).
Resources for pharmacies to achieve Healthy Living Pharmacy (HLP) Level 1 status.
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
A pathway summarising the processes pharmaceutical companies should follow when preparing to launch new products in the UK.
Guidance for manufacturers who source their own-branded products from another company.
We can provide access to world-class regulatory knowledge, expertise and experience from within the MHRA.
Guidance for Marketing Authorisation (MA) applicants on providing consent to share operational information during the MA application process.
Confirmation of the regulation 251 of the Human Medicines Regulation following the Brexit transition.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).